NDAORALTABLETPriority Review
Lifecycle
Pre-Launch
Clinical Trials
1
Data completeness
1/8 — Limited
Priority Review
Drug data last refreshed 9h ago · AI intelligence enriched 1w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
Darunavir and ritonavir is an oral fixed-dose combination tablet containing a protease inhibitor (darunavir) and a pharmacokinetic booster (ritonavir) for the treatment of HIV-1 infection. This combination is indicated for antiretroviral-naive and treatment-experienced patients with HIV-1. Ritonavir enhances darunavir plasma concentrations, enabling lower dosing and improved efficacy.
Pre-Launch
Pre-launch stage suggests active recruitment across commercial, regulatory, and medical teams to prepare for market entry.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Clinical Trials (1)
A Single-arm, Open-label, Study to Assess the Pharmacokinetics of Darunavir and Ritonavir, Darunavir and Cobicistat, Etravirine, and Rilpivirine in HIV-1 Infected Pregnant Women
Started Apr 2009
77 enrolled
HIVHIV InfectionsPregnancy
Career Relevance
Working on this pre-launch product offers early-stage career exposure to regulatory approval, commercial launch planning, and competitive market positioning in HIV care. Opportunities exist across regulatory, commercial, and medical functions as the team mobilizes for market entry.
Brand Manager
Worked on DARUNAVIR AND RITONAVIR at Viatris (2)? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.